MARCH 2025 NEWSLETTER
The newsletter of the Feinberg School of Medicine Research Office
 |
Predicting Disease Risk, Improving Patient Outcomes |
|
Investigators are advancing research to support proactive responses in diagnosing and preventing chronic diseases. Across departments, scientists at Feinberg are pursuing new ways of testing to determine a person’s risk of developing chronic conditions. From genetic testing to blood tests, there are new innovations that could help prevent disease and empower people to stay healthier longer. |
 |
Weese-Mayer Honored with 2025 Stern Award |
|
Debra E. Weese-Mayer, MD, the Beatrice Cummings Mayer Professor of Pediatric Autonomic Medicine at Feinberg and chief of the Center for Autonomic Medicine in Pediatrics (CAMP) at Ann & Robert H. Lurie Children’s Hospital of Chicago, has been awarded the 2025 Paula H. Stern Award for Outstanding Women in Science and Medicine. |
Faculty ProfileIdentifying New Therapeutic Targets to Prevent Vision LossJeremy Lavine, MD, PhD, is an assistant professor of Ophthalmology and of Medicine in the Division of Rheumatology. His laboratory investigates the role of the innate immune system, specifically macrophages, in ocular health and disease. |
|
Student ProfileUtilizing Genetics to Investigate PCOSRosie Bauer is a fifth-year PhD student in the Driskill Graduate Program. In the laboratory of Margrit Urbanek, PhD, associate professor of Medicine in the Division of Endocrinology, Bauer’s research centers on understanding the genetics at play in polycystic ovary syndrome (PCOS). |
|
Staff ProfileProviding Valuable News and Research StoriesBrooke Morris-Chott is the senior publications editor for Feinberg’s Office of Communications. She manages the medical school’s flagship publication, Northwestern Medicine magazine, and serves as the editor for newsletters and publications produced by Feinberg’s Office of Communications. |
|
Campus Events |
||||||||
|
Research in the NewsNPR, March 5 WGN, March 5 ABC News, February 20 |
NUCATS CornerEQuaTR Conference April 28The Enhancing Quality in the Translational Research Workforce (EQuaTR) Conference offers the opportunity for clinical research staff to learn from leaders in the field, gaining practical knowledge on current trends and issues in clinical research. EQuaTR is presented by the NUCATS Institute, the Institute for Translational Medicine, and the UIC Center for Clinical and Translational Science, and is open to professionals in clinical and translational research including clinical research coordinators, research nurses, monitors, project and site managers, investigators, regulatory staff, research assistants and allied health professionals. |
|
Sponsored ResearchImproving Mucosal Melanoma Therapy by Harnessing the Immunogenicity of r3LCMV
|
|
Sponsored ResearchDysregulated Epigenetic Control in Leukemogenesis
|
|
Breakthroughs PodcastIntervening Earlier in Mental Healthcare for Kids with Lauren Wakschlag, PhDA new $11.7 million award from the National Institute of Mental Health aims to help Northwestern Medicine investigators move the dial on the youth mental health crisis. In this episode, Lauren Wakschlag, PhD, who is co-leading this grant, explains how the team will implement evidence-based developmental decision tools to determine “when to worry” about young children's mental health. |
|
New FacultyKatherine Borden, PhD, joined Feinberg as Hospira Foundation Professor of Translational Cancer Biology in November 2024. Her lab focuses on understanding the mechanisms and impact of dysregulated RNA metabolism in cancer focusing on Acute Myeloid Leukemia. She has unearthed novel modes by which cancer cells hijack genetic information, in the form of messenger RNA, and demonstrated new mechanisms by which RNA maturation and RNA export influence cell physiology and support cancer growth. Previously, she was professor at University of Montreal in Quebec, Canada for more than two decades. She has received many awards for this work including selected as a Stohlman Scholar of the Leukemia and Lymphoma Society USA, Distinguished Scientist of the Canadian Society for Clinical Investigation, CSMB Canadian Science Publishing Senior Investigator Award and was inducted as a fellow of the Royal Society of Canada in 2022 and as Fellow of the Canadian Academy of Health Sciences. |
|
Galter LibraryNew Research Integrity Tools AvailableEnsuring research integrity is essential to maintaining the highest standards of academic publishing. To support Feinberg investigators in this effort, faculty and staff now have access to two powerful tools: Proofig and iThenticate available through Galter Library. |
|
High Impact ResearchShanbhag NM, Padmanabhan JL, Zhang Z, Harel BT, Jia H, Kangarloo T, Yin W, Dowling AV, Laurenza A, Khudyakov P, Galinsky K, Latzman RD, Simuni T, Weintraub D, Horak FB, Lustig C, Maruff P, Simen AA. An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial. JAMA Neurology. February 2025; 82(2):152-159. Shroff RT, King G, Colby S, Scott AJ, Borad MJ, Goff L, Matin K, Mahipal A, Kalyan A, Javle MM, El Dika I, Tan B, Cheema P, Patel A, Iyer R, Kelley RK, Thumar J, El-Khoueiry A, Guthrie KA, Chiorean EG, Hochster H, Philip PA. SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers. Journal of Clinical Oncology. February 2025; 43(5):536-544. Solitano V, Hogan M, Singh S, Danese S, Peyrin-Biroulet L, Zou G, Yuan Y, Sands BE, Feagan BG, Dulai PS, Narula N, Ma C, Jairath V. Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta-Analysis. Gastroenterology. February 2025; 168(2):344-356. Troyanovsky RB, Indra I, Troyanovsky SM. Actin-dependent α-catenin oligomerization contributes to adherens junction assembly. Nature Communications. February 2025; 16(1):1801-1801. |
Featured CoreAnalytical bioNanoTechnology Equipment CoreThe Analytical bioNanoTechnology Equipment Core (ANTEC) houses research equipment for evaluating materials and biological preparations, and offers 3D printing and 3D scientific illustration services. The core serves Northwestern University investigators, visiting scientists, and local industry researchers. Equipment
Services
|
Funding Opportunities
|
Thank You For ReadingWe are testing an updated format for this newsletter. We welcome your feedback. Please share it with us via email. |
|
|
